维普期刊资源整合服务平台（V6.5）

188篇 您的检索式：作者名="Kaye SB"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed,platinum sensitive ovarian cancer显示文摘	Kaye SB Poole CJ Bidzinksi M		0，，：	1
2	Imaging ovarian cancer and peritoneal metastases-current and emerging techniques显示文摘	Kyriazi S Kaye SB Desouza NM	2010	Nat Rev Clin Oncol2010，7，7：	1
3	Epothilones in the treatment of cancer 显示文摘	LARKIN JM KAYE SB	2006	Expert Opin lnvestig Drugs2006，15，6：	1
4	Tumor vasculature as a target for anticancer therapy显示文摘	Eatock MM Schatzlein A Kaye SB	2000	Cancer Treat Rev2000，26，3：	1
5	Ovarian cancer: can we reverse drug resistance? 显示文摘	Tan DS Ang JE Kaye SB	2008	Adv Exp Med Biol2008，622，：	1
6	Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia显示文摘	Kaye SB Chen SI Price G	2002	AAPOS2002，6，5：	1
7	New perspectives on molecular tar- geted therapy in ovarian clear cell carcinoma 显示文摘	Tan DS Miller RE Kaye SB	2013	Br J Cancer2013，108，8：	1
8	The prism bar-Prentice and frontal positions显示文摘	Kaye SB Ansons AM Green JR	1989	Eye1989，3，：	1
9	Protein kinasec in hibitors 显示文摘	Swannie Hc kaye SB	2002	curr oncol Rep2002，4，1：	1
10	Epstein-Barr virus (types 1 and 2)in the tear film in Sjogren's syndrome and HIV infection显示文摘	Willoughby CE Baker K Kaye SB	2002	J Med Virol2002，68，3：	1
11	Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromideformazan absorption on chemosensitivity determined by a novel tetrazolium-based assay 显示文摘	Plumb JA Milroy R Kaye SB	1989	Cancer Res1989，49，16：	1
12	Ovarian cancer: sWategies for overcoming resistance to chemotherapy显示文摘	Agarwal 1L Kaye SB	2003	Nat Rev Cancer2003，3，7：	1
13	Tumour vasculature as a target for anticancer therapy显示文摘	Schatzlein A Kaye SB	2000	Cancer Treat Rev2000，26，：	1
14	Ovarian cancer:strategies for overconfing resistance to chemotherapy显示文摘	Agarwal R Kaye SB	2003	Nat Rev Cancer2003，3，：	1
15	Epothilones in the treatment of cancer 显示文摘	Larkin JM Kaye SB	2006	Expert ()pin Investig Drugs2006，15，6：	1
16	Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers显示文摘	Powell C Mikropoulos C Kaye SB		0，，：	1
17	Meeting the challenge of ascites in ovarian cancer:new avenues for therapy and research显示文摘	Kipps E Tan DS Kaye SB	2013	Nat Rev Cancer2013，13，4：	1
18	Phase II, open-label, randomized, muhicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubiein in patients with BRCA1 or BRCA2 mutations and recurrent ovarian Cancer 显示文摘	Kaye SB Lubinski J Matulonis U	2012	Clin Oncol2012，30，4：	1
19	Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer 显示文摘	Poveda A Kaye SB McCormack R	2011	Gynecol Oncol2011，122，3：	1
20	Retinoids:present role and future potential显示文摘	Evans TRJ Kaye SB	1999	Br J Cancer1999，80，12：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示